NCT05023564 PUMCH Dementia Longitudinal Cohort Study
| NCT ID | NCT05023564 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Dementia |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2020-12-01 |
| Primary Completion | 2040-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2020-12-01 with a primary completion date of 2040-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PUMCH Dementia Cohort is a hospital-based, observational study of Chinese elderly with cognitive impairment.
Eligibility Criteria
Inclusion Criteria: * Neurodegenerative dementia diagnosis based on 2011 NIA-AA criteria of Dementia * Fixed care giver and can follow up regularly Exclusion Criteria: * Not demented, including MCI * Systemic severe diseases and severe vision or hearing problem effecting follow up and neuropsychological evaluation * Without fixed care giver * Reject informed consent * Expected life shorter than 2 years
Contact & Investigator
Chenhui Mao, Doctor
PRINCIPAL INVESTIGATOR
Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT05023564 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05023564 currently recruiting?
Yes, NCT05023564 is actively recruiting participants. Contact the research team at maochenhui@pumch.cn for enrollment information.
Where is the NCT05023564 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05023564 clinical trial?
NCT05023564 is sponsored by Peking Union Medical College Hospital. The principal investigator is Chenhui Mao, Doctor at Peking Union Medical College Hospital. The trial plans to enroll 20,000 participants.